Osang Healthcare Co.,Ltd (KOSDAQ:036220)
12,910
-420 (-3.15%)
Apr 2, 2025, 3:30 PM KST
Osang Healthcare Co.,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -11,364 | 116,436 | 40,647 | 1,460 | 124,996 | Upgrade
|
Depreciation & Amortization | 7,156 | 6,335 | 5,413 | 3,956 | 2,673 | Upgrade
|
Loss (Gain) From Sale of Assets | -6.69 | 1,640 | -216.07 | -5.33 | 152.58 | Upgrade
|
Asset Writedown & Restructuring Costs | 18.43 | 9.69 | 0.07 | 0.68 | 10.94 | Upgrade
|
Loss (Gain) From Sale of Investments | 56.54 | 104.99 | 984.88 | -1,321 | -60.59 | Upgrade
|
Loss (Gain) on Equity Investments | 2,791 | -925.89 | -259.8 | -913.21 | -733.43 | Upgrade
|
Stock-Based Compensation | 1,348 | 1,860 | 2,696 | 3,094 | 2,386 | Upgrade
|
Provision & Write-off of Bad Debts | -460.56 | 3,323 | 2,069 | 21,600 | 2,186 | Upgrade
|
Other Operating Activities | -27,923 | 11,626 | 18,811 | -24,190 | 40,254 | Upgrade
|
Change in Accounts Receivable | 1,804 | 20,216 | -18,527 | 1,128 | -32,186 | Upgrade
|
Change in Inventory | -7,995 | 20,101 | -26,946 | 4,193 | -37,271 | Upgrade
|
Change in Accounts Payable | -4,885 | -14,581 | 12,089 | -1,015 | 2,311 | Upgrade
|
Change in Unearned Revenue | 11.33 | 9.9 | 5.81 | - | - | Upgrade
|
Change in Other Net Operating Assets | 682.85 | -13,559 | 5,586 | 2,819 | -3,559 | Upgrade
|
Operating Cash Flow | -38,767 | 152,596 | 42,353 | 10,807 | 101,162 | Upgrade
|
Operating Cash Flow Growth | - | 260.29% | 291.90% | -89.32% | 14958.27% | Upgrade
|
Capital Expenditures | -27,810 | -35,703 | -11,702 | -9,040 | -7,822 | Upgrade
|
Sale of Property, Plant & Equipment | 54.19 | 14,607 | 715.05 | 87.98 | 6.38 | Upgrade
|
Sale (Purchase) of Intangibles | -4,629 | -179.72 | -199 | -858.77 | -141.04 | Upgrade
|
Investment in Securities | -23,808 | -34,251 | -16,309 | 3,722 | -15,835 | Upgrade
|
Other Investing Activities | 0 | 0 | - | 10 | -20 | Upgrade
|
Investing Cash Flow | -56,192 | -55,526 | -27,495 | -6,079 | -23,812 | Upgrade
|
Short-Term Debt Issued | - | 14,850 | - | 100 | 2,100 | Upgrade
|
Total Debt Issued | - | 14,850 | - | 100 | 2,100 | Upgrade
|
Short-Term Debt Repaid | - | -14,850 | - | -2,100 | -15,100 | Upgrade
|
Long-Term Debt Repaid | -477.49 | -592.47 | -625.08 | -302.05 | - | Upgrade
|
Total Debt Repaid | -477.49 | -15,442 | -625.08 | -2,402 | -15,100 | Upgrade
|
Net Debt Issued (Repaid) | -477.49 | -592.47 | -625.08 | -2,302 | -13,000 | Upgrade
|
Issuance of Common Stock | 23,154 | 714.38 | 2,570 | 294.61 | - | Upgrade
|
Repurchase of Common Stock | -4,994 | - | - | - | - | Upgrade
|
Dividends Paid | -25,169 | -25,349 | -24,895 | -24,534 | - | Upgrade
|
Other Financing Activities | 13.23 | - | - | 0 | 1.05 | Upgrade
|
Financing Cash Flow | -7,473 | -25,227 | -22,950 | -26,541 | -12,999 | Upgrade
|
Foreign Exchange Rate Adjustments | 2,180 | -366.29 | -874.74 | 18.02 | -842.3 | Upgrade
|
Net Cash Flow | -100,253 | 71,476 | -8,966 | -21,795 | 63,509 | Upgrade
|
Free Cash Flow | -66,577 | 116,893 | 30,651 | 1,768 | 93,340 | Upgrade
|
Free Cash Flow Growth | - | 281.36% | 1634.00% | -98.11% | - | Upgrade
|
Free Cash Flow Margin | -82.72% | 32.85% | 15.81% | 1.34% | 36.18% | Upgrade
|
Free Cash Flow Per Share | -4903.48 | 8956.02 | 2387.99 | 143.73 | 7041.88 | Upgrade
|
Cash Interest Paid | 27.17 | 49 | 25.12 | 8.75 | 402.69 | Upgrade
|
Cash Income Tax Paid | 17,022 | 33,836 | 1,311 | 36,540 | 247.73 | Upgrade
|
Levered Free Cash Flow | -69,284 | 93,874 | 34,689 | 7,542 | - | Upgrade
|
Unlevered Free Cash Flow | -69,267 | 93,910 | 34,705 | 7,552 | - | Upgrade
|
Change in Net Working Capital | 29,321 | -33,597 | -8,842 | -14,842 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.